Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
mean decrease » a decrease (Expand Search)
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
mean decrease » a decrease (Expand Search)
-
8341
Raw data 16–20.
Published 2025“…These results should be considered when using a wide step width as a gait retraining method for managing flat-footed individuals.…”
-
8342
Demographics, SD= Standard Deviation.
Published 2025“…These results should be considered when using a wide step width as a gait retraining method for managing flat-footed individuals.…”
-
8343
Raw data 6–9 and 15.
Published 2025“…These results should be considered when using a wide step width as a gait retraining method for managing flat-footed individuals.…”
-
8344
Raw data 1–5.
Published 2025“…These results should be considered when using a wide step width as a gait retraining method for managing flat-footed individuals.…”
-
8345
Raw data 10–14.
Published 2025“…These results should be considered when using a wide step width as a gait retraining method for managing flat-footed individuals.…”
-
8346
Coordination angle during running.
Published 2025“…These results should be considered when using a wide step width as a gait retraining method for managing flat-footed individuals.…”
-
8347
Gait retraining with biofeedback.
Published 2025“…These results should be considered when using a wide step width as a gait retraining method for managing flat-footed individuals.…”
-
8348
Coordination angle during walking.
Published 2025“…These results should be considered when using a wide step width as a gait retraining method for managing flat-footed individuals.…”
-
8349
-
8350
Inhibition of MRSA and MSSA biofilm growth <i>in vitro</i> with different concentrations of eugenol.
Published 2015“…<p>(A) Decreased biofilm biomass detected using the microtiter plate assay. …”
-
8351
Connectivity between the left nucleus accumbens and two clusters.
Published 2025“…After intervention there was a significant decrease in the FR group (mean at V1: 0.249 ± 0.094, mean at V5: 0.130 ± 0.101, difference: −0.119 ± 0.097, p < 0.001) and a significant increase in the SM group (mean at V1: 0.156 ± 0.113, mean at V5: 0.287 ± 0.107, difference: 0.131 ± 0.066, p < 0.001). …”
-
8352
Patterns of lifetime use of substances by gender.
Published 2023“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”
-
8353
S1 Data -
Published 2023“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”
-
8354
Factors associated with substance use.
Published 2023“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”
-
8355
Factors associated with personality traits.
Published 2023“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”
-
8356
-
8357
-
8358
Data supporting this article.
Published 2025“…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”
-
8359
Demographic and clinical data at baseline.
Published 2025“…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”
-
8360
Changes in clinical variables.
Published 2025“…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”